Primary record
InChI=1/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H
- 库存
- 8,357 克
- 纯度
- 98.5 %
- CAS
- 739-71-9
化合物标识与属性
- CAS
- 739-71-9
- PubChem CID
- 5584
- SMILES
- CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C
- Canonical SMILES
- CC(CN(C)C)CN1c2ccccc2CCc2ccccc21
名称与同义词
- trimipramine
- Trimeprimine
- Surmontil
- Trimeproprimine
- Sapilent
- beta-Methylimipramine
- Trimeprimina
- Trimipramina
- Trimipraminum
- Surmontyl
- Trimeproprimin
- (+)-Trimipramine
- (-)-Trimipramine
- Rhotrimine
- Stangyl
- Trimipramine maleate
- Trimeprimina [Italian]
- Trimepramine
- NovoTripramine
- NuTrimipramine
- Temaril
- ApoTrimip
- Novo Tripramine
- Nu Trimipramine
- 739-71-9
- Apo Trimip
- ( )-Trimipramine
- Trimipraminum [INN-Latin]
- Trimipramina [INN-Spanish]
- Beta, Trimipramin
- Rhotrimine (TN)
- Surmontil (TN)
- Stangyl (TN)
- nchembio747-comp5
- Trimipramine Mesylate
- Trimipraminneurazpharm
- 7162 RP
- Trimipramin neurazpharm
- Trimipramine maleate salt
- IL 6001
- Spectrum_001422
- .beta.-Methylimipramine
- Trimipramine (USAN/INN)
- Trimipramine [USAN:INN:BAN]
- CHEMBL644
- RefChem:56471
- Trimipramine, (-)-Isomer
- UNII-QJ9MUH57H8
- Prestwick0_000806
- Prestwick1_000806
- Prestwick2_000806
- Prestwick3_000806
- Spectrum2_001530
- Spectrum3_001151
- Spectrum4_000759
- Spectrum5_001052
- 6S082C9NDT
- QJ9MUH57H8
- TRIMIPRAMINE [MI]
- UNII-6S082C9NDT
- IL-6001
- TRIMIPRAMINE [INN]
- D00HZV
- TRIMIPRAMINE [USAN]
- AC1L1KO8
- CHEBI:9738
- FI 6120
- RP-7162
- TRIMIPRAMINE [VANDF]
- Lopac0_001156
- Oprea1_375679
- SCHEMBL35144
- BSPBio_000671
- BSPBio_002701
- DTXSID8023715
- KBioGR_001118
- KBioSS_001902
- TRIMIPRAMINE [MART.]
- Trimipramine Monohydrochloride
- UNII-9K5931C1H5
- cc-184
- DivK1c_000093
- TRIMIPRAMINE [WHO-DD]
- TRIMIPRAMINE, (+)-
- TRIMIPRAMINE, (-)-
- EINECS 212-008-3
- SPBio_001320
- SPBio_002592
- ZSCDBOWYZJWBIY-UHFFFAOYSA-N
- BPBio1_000739
- DTXCID003715
- GTPL7317
- orb1705107
- Trimipramine [USAN:BAN:INN]
- SCHEMBL29373768
- 7162-RP
- HY-B1213A
- KBio1_000093
- KBio2_001902
- KBio2_004470
- KBio2_007038
- KBio3_002201
- BRN 1321466
- CID5584
- N06AA06
- NINDS_000093
- 10633 RP
- 10645 RP
- GLXC-06993
- 9K5931C1H5
- BCP06247
- C20H26N2
- FI-6120
- Trimipramine 1.0 mg/ml in Methanol
- BDBM50240410
- EBC-26496
- MFCD00242595
- STL483796
- 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile
- 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine
- AKOS015962182
- 10645RP
- C20-H26-N2
- CCG-205230
- DB00726
- J6.960D
- RL04798
- SDCCGSBI-0051123.P004
- IDI1_000093
- NCGC00016013-02
- NCGC00016013-03
- NCGC00016013-11
- NCGC00162356-01
- 4CA-1282
- AC-15969
- BC209805
- J53.921J
- J86.105G
- LS-60463
- LS-60464
- LS-60465
- RP-10663
- 3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethylpropan-1-amine
- 5-(3-(Dimethylamino)-2-methylpropyl)-10,11-dihydro-5H-dibenz(b,f)azepine
- SBI-0051123.P003
- 2'-Metil-3'-dimetilamino-propil-5-iminodibenzile [Italian]
- 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine
- AB00053646
- CS-0013853
- FT-0764503
- NS00000421
- 10,11-dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propanamine
- 5-20-08-00099 (Beilstein Handbook Reference)
- 1-(3-Dimethylamino-2-methylpropyl)-4,5-dihydro-2,3:6,7-dibenzazepine
- 10,11-Dihydro-5-(3-dimethylamino-2-methylpropyl)-5H-dibenz(b,f)azepine
- D00394
- 20498-EP2275420A1
- 20498-EP2298764A1
- 20498-EP2298765A1
- 20498-EP2305260A1
- 20498-EP2305652A2
- 20498-EP2314585A1
- 5-(3-Dimethylamino-2-methylpropyl)iminodibenzil
- 5-(gamma-Dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
- AB00053646_10
- AB00053646_11
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-
- A847268
- EN300-24410256
- L000969
- Q423498
- 3564-75-8
- 5-(gamma-dimethylamino-beta-methylpropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-
- 10,11 Dihydro-N,N,beta-trimethyl-5H-dibenz(b,f)azepine-5-propanamine
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (-)-
- BRD-A19195498-050-05-9
- BRD-A19195498-050-09-1
- BRD-A19195498-050-13-3
- BRD-A19195498-050-14-1
- 3564-66-7
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (+)-
- 5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)-2-methylpropyl)-, (-)-
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-10,11-dihydro-, (+)-
- 5H-Dibenz[b,f]azepine-5-propanamine,10,11-dihydro-N,N,b-trimethyl-
- 5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)-2-methylpropyl)-
- 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-
- 10,11-Dihydro-N,N,beta-trimethyl-5H-dibenz[b,f]azepine-5-propan-1-amine
- 3-(5,6-dihydrobenzo(b)(1)benzazepin-11-yl)-N,N,2-trimethylpropan-1-amine
- 5-(3-Dimethylamino-2-methylpropyl)-10,11-dihydro-5H-dibenz[b,f]azepine
- 5-[2-Methyl-3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-
- (+)-5-[3-(Dimethylamino)-2-methylpropyl]-10,11-dihydro-5H-dibenz[b,f]azepine
- (-)-5-(3-Dimethylamino-2-methylpropyl)-10,11-dihydro-5H-dibenz[b,f]azepine
- 10,11-DIHYDRO-N,N,BETA-TRIMETHYL-5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE
- 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-propanamine
- 3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N,2-trimethyl-1-propanamine #
- 3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N,2-trimethyl-propan-1-amine
- 5-(.gamma.-Dimethylamino-.beta.-methylpropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine
- 5H-DIBENZ(B,F)AZEPINE, 5-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-10,11-DIHYDRO-, D-
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-, (+)-
- 5H-DIBENZ(B,F)AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N,N,.BETA.-TRIMETHYL-, (-)-
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (+)-(9CI)
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)-
- 5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N,beta-trimethyl-, (-)-(9CI)
- 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-, (-)-
- 5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)-2-methylpropyl]-10,11-dihydro-, d-
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,.beta.-trimethyl-, (-)-
- Trimipramine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- (3-(2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)-2-methylpropyl)dimethylamine
- (3-(2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,11,13-hexaen-2-yl)-2-methylpropyl)dimethylamine
- (3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}-2-methylpropyl)dimethylamine
- (3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}-2-methylpropyl)dimethylamine
- 212-008-3
- 5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N,beta.-trimethyl-, (2Z)-2-butenedioate (1:1)
- InChI=1/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H